IFF · International Flavors & Fragrances Inc · Executive Compensation
$83.48
-1.77 (-2.08%)
At close · Sep 30
Return incl. dividend (before tax)
Market Cap
$21.86B
Shares
255.15M
Volume · Sep 30
1.91M
Avg daily vol (3M)
1.71M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Rustom Jilla | CFO Nicolas Mirzayantz | $2,549,494 |
| Matthias Haeni | Former Divisional Chief Executive Officer, Taste Anne Chwat | $1,631,234 |
| Richard O’Leary | — | $1,602,359 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Divisional Chief | Executive Officer, Scent | $2,431,341 |
| Richard O’Leary | CFO Nicolas Mirzayantz | $1,862,399 |
| Former CFO | — | $1,862,399 |
| Matthias Haeni | Former Divisional Chief Executive Officer, Taste Anne Chwat | $1,742,273 |
| Former General | Counsel | $1,494,206 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Matthias Haeni | Former Divisional Chief Executive Officer, Taste Anne Chwat | $4,285,390 |
| Divisional Chief | Executive Officer, Scent | $2,088,528 |
| Richard O’Leary | CFO Nicolas Mirzayantz | $2,064,020 |
| Former CFO | — | $2,064,020 |
| Former General | Counsel | $1,762,347 |
Fiscal 2017
| Executive | Role | Total |
|---|---|---|
| Matthias Haeni | Divisional Chief Executive Officer, Taste Anne Chwat | $3,156,660 |
| Divisional Chief | Executive Officer, Scent | $2,572,065 |
| Richard O’Leary | CFO Nicolas Mirzayantz | $1,895,797 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Richard Mulligan | independent director | Appointed | 2025-10-22 |
| Brett Icahn | director | Appointed | 2025-10-22 |
| Marc Birenkrant | Controller & Chief Accounting Officer | Appointed | 2025-08-07 |
| Paul Fribourg | director of the board of directors of the Company | Appointed | 2025-07-30 |
| Jesus Mantas | director of the board of directors of the Company | Appointed | 2025-07-30 |
| Virginia Drosos | director | Appointed | 2025-06-09 |
| Leticia Goncalves Lourenço | President, Health & Biosciences | Appointed | 2025-02-20 |
| Mehmood Khan | director | Appointed | 2024-12-19 |
| Vincent Intrieri | director | Appointed | 2024-12-19 |
| Cynthia Jamison | director | Appointed | 2024-12-19 |
| Christina Gold | director | Retired | 2024-12-19 |
| Kevin O'Byrne | Chair of the Board | Appointed | 2024-12-19 |
| John Davidson | director | Retired | 2024-12-19 |
| Roger W. Ferguson, Jr. | director | Retired | 2024-12-19 |
| Glenn Richter | Executive Vice President, Chief Financial Officer | Retired | 2024-12-10 |
| Michael DeVeau | Executive Vice President, Chief Financial Officer | Appointed | 2024-12-10 |
| Margarita Paláu-Hernández | board of directors | Appointed | 2024-05-30 |
| Glenn Richter | Chief Financial and Business Transformation Officer ("CFO") | Retired | 2024-05-06 |
| Simon Herriott | President, Scent | Resigned | 2024-03-21 |
| Frank Clyburn | Chief Executive Officer | Resigned | 2024-01-11 |
| J. Erik Fyrwald | CEO | Appointed | 2024-01-11 |
| J. Erik Fyrwald | director of the Board | Appointed | 2024-01-11 |
| Roger W. Ferguson, Jr. | Chair of the Board | Appointed | 2023-04-12 |
| Kevin O'Byrne | member of the Board | Appointed | 2023-02-27 |
| Edward D. Breen | director | Retired | 2023-02-27 |